“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

News archive

  • Mar
    CoMMiTMenT Coordinator Dr Lars Kaestner gives invited presentation at the German Pharm-Tox Summit
    From 29th February to 3rd March 2016, the ‘German Pharm-Tox Summit’ took place at the Free University in Berlin. This prestigious event brings together basic scientists and clinical pharmacologists every year, thus enabling intensive knowledge transfer. Within the ‘Advanced Courses in Pharmacology’, Dr Lars Kaestner, CoMMiTMenT coordinator of Saarland University, gave an invited presentation on...
  • Dec
    Epigem makes progress on CoMMiTMenT
    Epigem, a high-tech British micro engineering company, has made significant progress on the CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project including mimicking functions of the spleen. The project’s clinical partners are now testing devices created by Epigem, which are based on their microfluidics abilities. These work by...
  • Nov
    CoMMiTMenT Consortium gathers for 4th Progress Meeting in London
    Almost exactly 2 years after the project’s kick-off, CoMMiTMenT coordinator Lars Kaestner of Saarland University welcomed the CoMMiTMenT consortium at the Royal Society of Medicine in London, where the Marcus Beck Library provided a dignified setting for the 4th Progress Meeting. As dense fog cut off London airports from traffic, some participants’ flights were cancelled; however, the technical...
  • Oct
    The Campaign for a European Year for Rare Diseases 2019
    Every year, the EU chooses a specific subject to encourage debate and dialogue within and between European countries. The aim of the European Year is to raise awareness of a certain topic. A European Year can also send a strong political signal to gain a commitment from EU institutions and Member State governments that the subject will be taken into consideration in future policymaking. 2019...
  • Oct
    Orphanet publishes an updated report on Rare Diseases Registries in European Union
    Registries and databases are essential key tools for the improvement in patient care and health planning, constituting the only way to reach a reasonable sample size for epidemiological and/or clinical research. The importance of registries is even greater when it comes to rare diseases, where the small number of patients and their geographical dispersion results in a general unawareness of the...
  • Oct
    CoMMiTMenT Partners Coorganizing 6th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS and 1st Dutch-Belgian meeting for patients and health professionals
    The 6th European Symposium on Rare Anaemias will take place in Amsterdam from November 21-22, 2015 and has been jointly organized by ENERCA (European Network for Rare and Congenital Anaemias), UMCU (Universitair Medisch Centrum Utrecht) and ERASME (Hôpital Erasme).  CoMMiTMenT consortium members UMCU and ENERCA- related IDIBAPS (Consorci Institut d’Investigacions Biomediques August PI I...
  • Oct
    Founder of CoMMiTMenT consortium member OptoRobotix invited to present at IEEE NANO 2016
    Prof. Dr Jesper Glückstad, founder of DTU Fotonik spin-off OptoRobotix, a consortium member of the EC-funded CoMMiTMenT project, has been invited to give a plenary talk focusing on “Nano-biophotonics enabled by optical micro-robotics“ at the prestigious 6th International Conference on Nanotechnology taking place in Sendai/ Japan from 22 to 25 August 2016. IEEE Nano is one of the largest...